Addressing the unmet needs of patients with BRAF-mutated melanoma in Latin America: Expert perspective.

ABSTRACT: Melanoma represents an increasing public health burden with extensive unmet needs in Latin America (LA). A mutation in the BRAF gene is present in approximately 50% of all melanomas in White populations and is a target of precision medicine, with the potential to dramatically improve patient outcomes. Thus, increased access to BRAF testing and therapy is LA must be explored. At a multi-day conference, a panel of Latin American experts in oncology and dermatology were provided with questions to address the barriers limiting access to testing for BRAF mutation in patients with melanoma in LA, who may be eligible for targeted therapy to improve their prognosis. During the conference, responses were discussed and edited until a consensus on addressing the barriers was achi

SUBMITTER: Salman P 

PROVIDER: S-EPMC10043339 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature